PREVENTING PREMATURE LUTEINISING HORMONE (LH) SURGE 1
![slider left background image](https://hcp.ferring.co.uk/wp-content/uploads/2022/09/Fyremadel-Logo-1-white-min.png)
![slider left background image](https://hcp.ferring.co.uk/wp-content/uploads/2022/09/Flowers-Fyremadel-2-15jun2023.png)
![slider right background image](https://hcp.ferring.co.uk/wp-content/uploads/2022/09/Banners-Brand-Home-Pages-1-Fyremadel-e1616171654988-min.jpeg)
![slider right background image](https://hcp.ferring.co.uk/wp-content/uploads/2022/09/Banners-Brand-Home-Pages-1-Fyremadel-e1616171654988-min.jpeg)
Adverse Event reporting information can be found in footer
Request a Meeting
GnRH antagonist to prevent premature LH surge in women undergoing controlled ovarian stimulation1
Job Code: UK-FYR-2300001 - Date of preparation: August 2023